Skip to content

Clinical trials

Hypercholesterolemia trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Belgium Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20082
20114
20125
20139
20144
20154
20165
20172
20201
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated6
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen19
Sanofi8
Pfizer4
Novartis Pharmaceuticals3
AstraZeneca2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Kastle Therapeutics, LLC1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Universitair Ziekenhuis Brussel1
Universiteit Antwerpen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia43
Hyperlipidemias12
Dyslipidemias9
Hyperlipoproteinemia Type II4
Cardiovascular Diseases3
Homozygous Familial Hypercholesterolemia3
Atherosclerosis2
Diabetes Mellitus2
Lipid Metabolism Disorders2
Metabolic Diseases2

Trials

Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.